공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

심혈관 수술 기기 : 기술과 세계 시장

Cardiovascular Surgical Devices: Technologies and Global Markets

리서치사 BCC Research
발행일 2016년 09월 상품 코드 136641
페이지 정보 영문 188 Pages
가격
US $ 2,750 ₩ 3,075,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,300 ₩ 3,690,000 PDF (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,960 ₩ 4,428,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,752 ₩ 5,313,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


심혈관 수술 기기 : 기술과 세계 시장 Cardiovascular Surgical Devices: Technologies and Global Markets
발행일 : 2016년 09월 페이지 정보 : 영문 188 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

심혈관 수술 기기 시장은 예측기간 중 9.4%의 연평균 성장률(CAGR)로 성장하여 2015년 약 370억 달러에서 2020년에는 572억 달러에 이를 것으로 예측됩니다.

세계의 심혈관 수술 기기(Cardiovascular Surgical Device) 시장을 조사했으며, 심혈관 질환·심장혈관수술·심장혈관수술용 각종 기기 개요 및 분류, 세계 주요 지역 및 국가에서의 심혈관 수술 실시 동향, 시장 추이와 예측, 의료기기 관련 법규제, 주요 기기 종류별 분석, 주요 기업 프로파일 등을 정리하여 전해드립니다.

제1장 서론

제2장 요약

제3장 심장혈관 수술 및 외과 기구에서의 IT 도입

  • 세계의 의료 IT 투자 개요
  • 심장혈관 정보 시스템
  • 관련 신기술
    • 로봇 보조 최소침습성 수술
    • 바이오마커

제4장 심혈관질환 및 심장혈관 수술 개요

  • 심혈관질환 분류
    • 협심증
    • 부정맥
    • 심근증
    • 울혈성 심부전
    • 선천성 심질환
    • 관상동맥질환(CAD)
    • 심장 감염증
    • 고혈압
    • 심근경색
    • 판막증
  • 심혈관질환 위험인자
  • 심장혈관 수술의 발전
  • 심장혈관 수술 분류
  • 심장혈관외과 기기 시장 동향

제5장 세계의 심혈관질환 및 심장혈관 수술 이용도

  • 서론
  • 미국의 심장혈관 수술
  • 유럽의 심장혈관 수술
  • 아시아태평양 지역의 심장혈관 수술
    • 의료제도
    • 심장혈관 수술 이용도
    • 심장혈관 기기 시장 추이와 예측
    • 의료기기 관련 규제 등

제6장 세계의 기존 심장외과 수술 기기 시장

  • 기존 심장외과 수술의 정의
  • 개흉수술
    • 관상동맥 우회술(CABG)
    • 심박동하 수술(Beating Heart Surgery)
    • 심방세동을 위한 개흉수술
    • Transmyocardial revascularization(TMR)
    • 심장이식 수술
    • 인공혈관 수술

제7장 세계의 심혈관 중재시술 기기 시장

  • 시술 개요
  • PCI 카테터 및 가이드와이어
  • 관상동맥 스텐트
  • 풍선성형술
  • 경카테터 대동맥변 치환술(TAVI)
  • 신장 신경제거술
  • 심혈관 중재시술에서의 로보틱스 이용

제8장 세계의 심장리듬 관리 기기 시장

  • 부정맥의 종류
  • 심방세동
  • 좌심방 부속기 배제 장치
  • 페이스메이커 및 CRT-PS
  • 제세동기(ICDS) 및 CRT-DS
  • Cardiac Lead 제거 시스템

제9장 세계의 Cardiac Ablation System 및 새로운 치료법 시장

  • Cardiac Ablation 개요
  • 기타 새로운 치료법

제10장 산업 정리통합, 미국의 의료비 상환 개정, 의료기기 산업의 규제 동향

  • 산업 정리통합
  • 미국의 의료비 상환 개정

제11장 미국 특허 분석

제12장 기업 개요

  • ABBOTT VASCULAR
  • ABIOMED INC.
  • ATRICURE INC.
  • BIOSENSORS INTERNATIONAL
  • BIOTRONIK INC., DIV. BIOTRONIK SE & CO KG
  • BIOVENTRIX INC.
  • BOSTON SCIENTIFIC CORP.
  • C. R. BARD INC.
  • CARDIACASSIST INC.(TANDEMLIFE)
  • CIRCULITE INC.
  • CORDIS CORP.
  • CORINDUS VASCULAR ROBOTICS
  • CRYOLIFE INC.
  • CVRX INC.
  • EDWARDS LIFESCIENCES CORP.
  • HEARTWARE INTERNATIONAL INC.
  • INTUITIVE SURGICAL
  • JARVIK HEART INC.
  • MAQUET CARDIOVASCULAR LLC
  • MEDTRONIC CORP.
  • MERIT MEDICAL SYSTEMS INC.
  • ON-X LIFE TECHNOLOGIES INC.
  • ORBUSNEICH
  • QVANTEQ AG
  • ST. JUDE MEDICAL INC.
  • SORIN GROUP SPA
  • SPECTRANETICS CORP.
  • SUNSHINE HEART INC.
  • SYNCARDIA SYSTEMS INC.
  • TERUMO CARDIOVASCULAR SYSTEMS
  • THORATEC CORP.
  • VOLCANO CORP.

도표

LSH 16.10.12

REPORT HIGHLIGHTS

The global market for cardiovascular surgical devices is expected to grow from nearly $37.0 billion in 2015 to $57.2 billion in 2020 at a compound annual growth rate of 9.4% from 2015-2020.

This report provides:

  • An overview of the global markets for cardiovascular surgical devices.
  • Analyses of global market trends, with data from 2014, 2015, and projections of CAGRs through 2020.
  • Incidence rates of cardiovascular diseases in the United States, WHO regions, and in selected countries.
  • Discussion of key cardiovascular surgical procedures, traditional and interventional surgery, and adoption of robotics in surgery.
  • Examination of procedures related to cardiac rhythm management, including devices and definitions.
  • Reviews of procedures and devices related to cardiac assist.
  • Patent analysis of various devices by year and by assignee.
  • Profiles of major players in the industry.

SCOPE OF REPORT

The scope of this study encompasses multiple technologies and procedures related to cardiovascular surgical devices. The study focused primarily on four categories of cardiovascular surgery: traditional (open), interventional, cardiac rhythm management (CRM) and cardiac ablation procedures. These procedure groupings are categorized logically so that comparisons can be made within procedural groups as well as across the cardiovascular surgical devices industry as a whole. Note that carotid artery surgery related to stroke, abdominal aortic aneurysm (AAA) surgery to correct aortic aneurysms, and surgical and stenting procedures designed to address peripheral vascular disease are not addressed in detail in this report.

BCC Research analyzes the industry on a worldwide basis from market, product and technology perspectives. Regulations and reimbursement issues and patents issued from 2011 through mid-2016 are also examined to identify patient safety, regulatory review and insurance coverage issues for stakeholders and potential stakeholders in this industry.

The report examines the cardiovascular surgery device industry in general, the types of technologies currently in use as well as future technological developments, and regulatory influences that affect product distribution. The industry structure section discusses the most active manufacturers with respect to relative market share, marketing strengths and forces that promote or hinder the growth of technologies. The technology sections detail historical (2014), and projected (2015 to 2020) market values.

ANALYST'S CREDENTIALS

Bhavna Joshi has more than six years of healthcare domain experience. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. After earning her MBA (marketing and finance stream) from Chennai University, she worked with major market research firms.

Joshi has authored several market research studies in the healthcare domain.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • SCOPE OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014 AND 2020 (%)

CHAPTER 3 - IMPLEMENTATION OF IT IN CARDIOVASCULAR SURGERIES AND DEVICES

  • AN OVERVIEW OF GLOBAL HEALTHCARE IT INVESTMENT
    • FIGURE 1 VENTURE CAPITAL FUNDING IN HEALTHCARE IT, 2013 AND 2014 ($ BILLIONS)
    • TABLE 1 INVESTMENTS IN HEALTHCARE IT, 2014 ($ MILLIONS)
  • CARDIOVASCULAR INFORMATION SYSTEM
    • TABLE 2 CVIS BENEFITS
    • FIGURE 2 ESSENTIAL ELEMENTS FOR CVIS
  • NOVEL TECHNOLOGIES IN CARDIOVASCULAR DEVELOPMENT
    • ROBOT-ASSISTED MINIMALLY INVASIVE SURGERIES
    • BIOMARKERS
      • TABLE 3 NOVEL TECHNOLOGIES IN CARDIOVASCULAR SURGERIES

CHAPTER 4 - OVERVIEW OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR SURGERY

  • CATEGORIES OF CARDIOVASCULAR DISEASE
    • TABLE 4 LEADING CARDIOVASCULAR CONDITIONS
  • ANGINA
    • FIGURE 3 PREVALENCE OF ANGINA PECTORIS BY AGE & SEX (%)
  • ARRHYTHMIAS
  • CARDIOMYOPATHY
  • CONGESTIVE HEART FAILURE
  • CONGENITAL HEART DISEASE
  • CORONARY ARTERY DISEASE (CAD)
    • FIGURE 4 PREVALENCE OF CAD BY AGE, 2014 (%)
  • HEART INFECTIONS
  • HYPERTENSION
  • MYOCARDIAL INFARCTION
  • VALVULAR HEART DISEASE
  • RISK FACTORS FOR CARDIOVASCULAR DISEASE
    • TABLE 5 CARDIOVASCULAR DISEASE RISK FACTORS
  • THE EVOLUTION OF CARDIOVASCULAR SURGERY
    • TABLE 6 KEY ADVANTAGES OF MINIMALLY INVASIVE CARDIAC SURGERY
  • CATEGORIES OF CARDIOVASCULAR SURGERY
  • CARDIOVASCULAR SURGICAL DEVICES MARKET TRENDS
  • INCREASE IN CVD FATALITIES TO DRIVE ADOPTION
    • TABLE 7 FACT SHEET OF CVD FATALITIES (MILLIONS/%)
  • MEDICAL TOURISM TO DRIVE APAC MARKET GROWTH
    • TABLE 8 PRICE DIFFERENCE IN INDIA AND THE UNITED STATES FOR CARDIAC-RELATED SURGERIES ($)
  • ACQUISITION IS KEY MARKET STRATEGY
  • KEY OBJECTIVES OF CARDIAC SURGERY MARKET
  • INTEGRATION OF INFORMATION TECHNOLOGY TO INCREASE MARKET GROWTH
    • FIGURE 5 GLOBAL MARKET FOR THERAPEUTIC APPLICATIONS FOR HYBRID OPERATING ROOMS
  • GROWING DEMAND FOR MINIMALLY INVASIVE SURGERY

CHAPTER 5 - GLOBAL IMPLICATIONS OF CARDIOVASCULAR DISEASE AND AVAILABILITY OF CARDIOVASCULAR SURGERY

  • INTRODUCTION
    • TABLE 9 HIGHEST DEATH RATE FOR HEART DISEASE, STROKE AND HIGH BLOOD PRESSURE BY COUNTRY, 2014 (PER 100,000 MEN AND WOMEN, AGES 35 TO 74)
    • TABLE 10 ADULT MORTALITY FROM CARDIOVASCULAR DISEASE AND DIABETES BY REGION, 2008 (ADULTS AGED 30-70, RATE PER 100,000 POPULATION)
  • CARDIOVASCULAR SURGERY IN THE UNITED STATES
    • HEALTHCARE SYSTEM OVERVIEW
      • TABLE 11 AMERICAN HEART ASSOCIATION DISEASE STATISTICS PREVALENCE AND MORTALITY, CARDIOVASCULAR DISEASE IN THE UNITED STATES, 2009 AND 2010
    • CARDIOVASCULAR SURGERY AVAILABILITY IN THE UNITED STATES
      • TABLE 12 LEADING U.S. CARDIOLOGY AND HEART SURGERY INSTITUTIONS, 2014-2015
    • U.S. MEDICAL DEVICE MARKET SIZE
      • FIGURE 6 U.S. MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
  • CARDIOVASCULAR SURGERY IN EUROPE
    • OVERVIEW
      • FIGURE 7 EUROPE MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
      • TABLE 13 MALE CVD DEATHS IN EUROPE BY COUNTRY, 2005-2010 (NO/%)
    • REGULATIONS REGARDING MEDICAL DEVICES IN EUROPE
    • GOVERNMENT SPENDING ON CVD
    • CARDIOVASCULAR SURGERY IN GERMANY
      • FIGURE 8 GERMANY MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
      • Availability of Cardiovascular Surgery in Germany
        • TABLE 14 LEADING GERMAN CARDIOLOGY AND HEART SURGERY INSTITUTIONS
    • CARDIOVASCULAR SURGERY IN THE UNITED KINGDOM
      • Healthcare System Overview
      • Availability of Cardiovascular Surgery in the United Kingdom
        • FIGURE 9 U.K. MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
        • TABLE 15 LEADING HOSPITALS IN THE U.K. OFFERING ADULT CARDIAC SURGERY
  • CARDIOVASCULAR SURGERY IN ASIA-PACIFIC REGION
    • OVERVIEW
      • FIGURE 10 ASIA-PACIFIC MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • CARDIOVASCULAR SURGERY IN JAPAN
      • Healthcare System Overview
        • FIGURE 11 JAPAN MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
      • Availability of Cardiovascular Surgery in Japan
        • TABLE 16 LEADING JAPANESE CARDIOLOGY AND HEART SURGERY INSTITUTIONS
      • Japanese Medical Device Market
      • Regulations in Japan
    • CARDIOVASCULAR SURGERY IN INDIA
      • Healthcare System Overview
        • FIGURE 12 INDIA MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
      • Availability of Cardiovascular Surgery in India
        • TABLE 17 LEADING INDIAN CARDIOLOGY AND HEART SURGERY INSTITUTIONS
      • Indian Medical Device Market
      • Regulations in India
    • CARDIOVASCULAR SURGERY IN CHINA-HEALTHCARE SYSTEM OVERVIEW
      • Availability of Cardiovascular Surgery in China
        • FIGURE 13 CHINA MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
      • Chinese Medical Device Market
      • Regulations in China

CHAPTER 6 - GLOBAL MARKETS FOR TRADITIONAL CARDIOVASCULAR SURGERY DEVICES

  • DEFINITION OF TRADITIONAL CARDIOVASCULAR SURGERY
    • TABLE 18 GLOBAL MARKET FOR TRADITIONAL CARDIOVASCULAR SURGICAL DEVICES, THROUGH 2020 ($ MILLIONS)
  • OPEN-HEART SURGERY
    • CORONARY ARTERY BYPASS GRAFTING (CABG) SURGERY
      • CABG-Related Device Market Players
        • TABLE 19 GLOBAL MARKET FOR OPEN-HEART SURGERY AND CABG-RELATED DEVICES, THROUGH 2020 ($ MILLIONS)
    • BEATING HEART SURGERY
      • TABLE 20 GLOBAL MARKET FOR BEATING HEART SURGERY DEVICES, THROUGH 2020 ($ MILLIONS)
    • OPEN-HEART SURGERY FOR ATRIAL FIBRILLATION
    • TRANSMYOCARDIAL REVASCULARIZATION SURGERY
      • Transmyocardial Revascularization Device Market Players
        • TABLE 21 GLOBAL MARKET FOR TRANSMYOCARDIAL REVASCULARIZATION DEVICES, THROUGH 2020 ($ MILLIONS)
    • HEART TRANSPLANT SURGERY
      • FIGURE 14 TRANSPLANTS BY ORGAN TYPE FROM JANUARY 1988 TO MAY 2016 (%/NO.)
    • CARDIOPROSTHETIC SURGERY
      • TABLE 22 LEADING MANUFACTURERS OF CARDIOPROSTHETIC SURGERY DEVICES
      • Total Artificial Hearts
        • TABLE 23 GLOBAL MARKET FOR TOTAL ARTIFICIAL HEARTS, THROUGH 2020 ($ MILLIONS)
      • Ventricular Assist Devices
        • Ventricular Assist Device Market Players
        • Ventricular Assist Device Market Size
          • TABLE 24 GLOBAL MARKET FOR VENTRICULAR ASSIST DEVICES, THROUGH 2020 ($ MILLIONS)
          • TABLE 25 LEADING VAD SUPPLIERS, 2014 AND 2015 ($ MILLIONS)
          • FIGURE 15 GLOBAL MARKET SHARES OF VENTRICULAR ASSIST DEVICE SUPPLIERS, 2014 (%)
      • Heart Valve Repair and Replacement
        • Heart Valve Market Players
        • Heart Valve Market Size
          • TABLE 26 GLOBAL MARKET FOR HEART VALVES EXCLUDING TAVI SYSTEMS, THROUGH 2020 ($ MILLIONS)
          • TABLE 27 LEADING HEART VALVE SUPPLIERS, 2014 ($ MILLIONS/%)
          • FIGURE 16 GLOBAL MARKET SHARES OF LEADING HEART VALVE SUPPLIERS, 2014 (%)
        • Recent Developments in the Heart Valve Market

CHAPTER 7 - GLOBAL MARKETS FOR INTERVENTIONAL CARDIOVASCULAR SURGERY DEVICES

  • PROCEDURE OVERVIEW
    • TABLE 28 GLOBAL MARKET FOR INTERVENTIONAL CARDIOVASCULAR SURGICAL DEVICES, THROUGH 2020 ($ MILLIONS)
  • PCI CATHETERS AND GUIDEWIRES
    • PCI CATHETER AND GUIDEWIRE MARKET PLAYERS
    • PCI CATHETER AND GUIDEWIRE MARKET SIZE
      • TABLE 29 GLOBAL MARKET FOR PCI BALLOON CATHETERS AND GUIDEWIRES, THROUGH 2020 ($ MILLIONS)
    • RECENT DEVELOPMENTS IN THE PCI CATHETER AND GUIDEWIRE MARKET
  • CORONARY ARTERY STENTS
    • TABLE 30 LEADING MANUFACTURERS OF CORONARY ARTERY STENTS
  • CORONARY ARTERY STENT MARKET SIZE
    • TABLE 31 GLOBAL MARKET FOR CORONARY ARTERY STENTS, THROUGH 2020 ($ MILLIONS)
  • CORONARY ARTERY STENT MARKET PLAYERS
    • FIGURE 17 GLOBAL MARKET SHARE FOR CORONARY STENT SUPPLIERS BY COMPANY, 2014 (%)
    • FIGURE 18 GLOBAL MARKET SHARE FOR CORONARY STENT SUPPLIERS BY REGION, 2020 (%)
    • RECENT DEVELOPMENTS IN THE CORONARY STENT MARKET
  • BALLOON VALVULOPLASTY SURGERY
  • TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)
    • TABLE 32 GLOBAL MARKET FOR TRANSCATHETER AORTIC VALVE IMPLANTATION SYSTEMS, THROUGH 2020 ($ MILLIONS)
    • FIGURE 19 MAJOR RESTRAINTS FOR ADOPTION OF TRANSCATHETER AORTIC VALVE IMPLANTATION (%)
  • RENAL DENERVATION SURGERY
    • TABLE 33 GLOBAL MARKET FOR RENAL DENERVATION SYSTEMS, THROUGH 2020 ($ MILLIONS)
  • USE OF ROBOTICS IN INTERVENTIONAL CARDIAC SURGERY
    • FIGURE 20 AVERAGE QUOTED PRICE: DA VINCI ROBOT MODELS, 2014 ($ MILLIONS)
    • TABLE 34 GLOBAL MARKET FOR ROBOTIC SURGERY SYSTEMS FOR CARDIOVASCULAR PROCEDURES, THROUGH 2020 ($ MILLIONS)

CHAPTER 8 - GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES

  • TYPES OF CARDIAC ARRHYTHMIAS
    • TABLE 35 MOST COMMON TYPES OF ARRHYTHMIAS
    • TABLE 36 GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES, THROUGH 2020 ($ MILLIONS)
  • ATRIAL FIBRILLATION
    • TREATMENTS FOR ATRIAL FIBRILLATION
  • LEFT ATRIAL APPENDAGE EXCLUSION DEVICES
    • TABLE 37 GLOBAL MARKET FOR LEFT ATRIAL APPENDAGE EXCLUSION DEVICES, THROUGH 2020 ($ MILLIONS)
  • PACEMAKERS AND CRT-PS
    • PACEMAKER AND CRT-P MARKET PLAYERS
    • PACEMAKER AND CRT-P MARKET SIZE
      • TABLE 38 GLOBAL MARKET FOR CARDIAC PACEMAKERS AND CRT-PS, THROUGH 2020 ($ MILLIONS)
      • FIGURE 21 GLOBAL MARKET SHARE FOR LEADING CARDIAC PACEMAKERS AND CRT-PS SUPPLIERS, 2014 (%)
    • RECENT DEVELOPMENTS IN THE PACEMAKER MARKET
  • DEFIBRILLATORS (ICDS) AND CRT-DS
    • DEFIBRILLATOR (ICD) AND CRT-D MARKET SIZE
      • TABLE 39 GLOBAL MARKET FOR DEFIBRILLATORS AND CRT-DS, THROUGH 2020 ($ MILLIONS)
    • DEFIBRILLATOR (ICD) AND CRT-D MARKET PLAYERS
      • FIGURE 22 GLOBAL MARKET SHARE FOR LEADING DEFIBRILLATOR AND CRT-D SUPPLIERS, 2014 (%)
    • RECENT TECHNOLOGICAL ADVANCES IN DEFIBRILLATORS
  • CARDIAC LEAD REMOVAL SYSTEMS

CHAPTER 9 - GLOBAL MARKET FOR CARDIAC ABLATION SYSTEMS AND OTHER EMERGING THERAPIES

  • OVERVIEW OF CARDIAC ABLATION
    • CARDIAC ABLATION MARKET PLAYERS
    • CARDIAC ABLATION MARKET SIZE
      • TABLE 40 GLOBAL MARKET FOR CARDIAC ABLATION SYSTEMS, THROUGH 2020 ($ MILLIONS)
  • OTHER EMERGING THERAPIES

CHAPTER 10 - INDUSTRY CONSOLIDATION, U.S. REIMBURSEMENT CHANGES AND TRENDS IN MEDICAL DEVICE INDUSTRY REGULATION

  • INDUSTRY CONSOLIDATION
    • TABLE 41 MAJOR ACQUISITIONS BY CARDIOVASCULAR SURGERY DEVICE SUPPLIERS, 2008-2015
  • U.S. REIMBURSEMENT CHANGES
    • TRENDS IN MEDICAL DEVICE INDUSTRY REGULATION
      • TABLE 42 RECENT FDA RECALLS OF CARDIOVASCULAR SURGERY DEVICES

CHAPTER 11 - U.S. PATENT ANALYSIS OF CARDIOVASCULAR DEVICES

  • SUMMARY OF DEVICE PATENTS
    • TABLE 43 U.S. CARDIAC PACEMAKER AND PACEMAKER-RELATED PATENTS, JANUARY 2011-DECEMBER 2015
  • IMPLANTABLE CARDIAC DEFIBRILLATORS AND RELATED DEVICES
    • TABLE 44 U.S. CARDIAC IMPLANTABLE DEFIBRILLATOR AND DEFIBRILLATOR-RELATED PATENTS, JANUARY 2011-DECEMBER 2015
  • CARDIAC-RELATED STENTS AND CORONARY STENTS
    • TABLE 45 U.S. CARDIAC-RELATED AND CORONARY ARTERY STENT PATENTS, JANUARY 2011-MAY 2016
  • CARDIAC CATHETERS (INCLUDING CARDIAC ABLATION CATHETERS)
    • TABLE 46 U.S. CARDIAC CATHETER AND RELATED PATENTS, JANUARY 2011-JANUARY 2016
  • CARDIAC VALVES AND RELATED DEVICES
    • TABLE 47 U.S. CARDIAC VALVES AND RELATED-EQUIPMENT PATENTS, JANUARY 2011-MAY 2016

CHAPTER 12 - COMPANY PROFILES

  • ABBOTT VASCULAR
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 48 ABBOTT CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • ABIOMED INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 49 ABIOMED CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • ATRICURE INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 50 ATRICURE CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • BIOSENSORS INTERNATIONAL
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 51 BIOSENSORS INTERNATIONAL CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • BIOTRONIK INC., DIV. BIOTRONIK SE & CO KG
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 52 BIOTRONIK CARDIOVASCULAR SURGERY PRODUCTS
  • BIOVENTRIX INC.
    • BUSINESS OVERVIEW
    • PRODUCT
  • BOSTON SCIENTIFIC CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 53 BOSTON SCIENTIFIC CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • C. R. BARD INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 54 C. R. BARD ELECTROPHYSIOLOGY CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • CARDIACASSIST INC.(TANDEMLIFE)
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 55 CARDIACASSIST CARDIOVASCULAR SURGERY PRODUCTS
  • CIRCULITE INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS
  • CORDIS CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 56 CORDIS AND BIOSENSE WEBSTER CARDIOVASCULAR SURGERY PRODUCTS
  • CORINDUS VASCULAR ROBOTICS
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS
  • CRYOLIFE INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 57 CRYOLIFE CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • CVRX INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
  • EDWARDS LIFESCIENCES CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 58 EDWARDS LIFESCIENCES CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • HEARTWARE INTERNATIONAL INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 59 HEARTWARE CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • INTUITIVE SURGICAL
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 60 INTUITIVE SURGICAL CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • JARVIK HEART INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 61 JARVIK HEART CARDIOVASCULAR SURGERY PRODUCT
  • MAQUET CARDIOVASCULAR LLC
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 62 MAQUET CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • MEDTRONIC CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 63 MEDTRONIC CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • MERIT MEDICAL SYSTEMS INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 64 MERIT MEDICAL CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • ON-X LIFE TECHNOLOGIES INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 65 ON-X LIFE TECHNOLOGIES CARDIOVASCULAR SURGERY PRODUCTS
  • ORBUSNEICH
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 66 ORBUSNEICH CARDIOVASCULAR SURGERY PRODUCTS
  • QVANTEQ AG
    • BUSINESS OVERVIEW
    • PRODUCTS
  • ST. JUDE MEDICAL INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 67 ST. JUDE MEDICAL CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • SORIN GROUP SPA
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 68 SORIN GROUP CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • SPECTRANETICS CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 69 SPECTRANETICS CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • SUNSHINE HEART INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS
  • SYNCARDIA SYSTEMS INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 70 SYNCARDIA CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • TERUMO CARDIOVASCULAR SYSTEMS
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 71 TERUMO CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • THORATEC CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 72 THORATEC CARDIOVASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • VOLCANO CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 73 VOLCANO CARDIOVASCULAR SURGERY PRODUCTS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: INVESTMENTS IN HEALTHCARE IT, 2014 ($ MILLIONS)
    • TABLE 2: CVIS BENEFITS
    • TABLE 3: NOVEL TECHNOLOGIES IN CARDIOVASCULAR SURGERIES
    • TABLE 4: LEADING CARDIOVASCULAR CONDITIONS
    • TABLE 5: CARDIOVASCULAR DISEASE RISK FACTORS
    • TABLE 6: KEY ADVANTAGES OF MINIMALLY INVASIVE CARDIAC SURGERY
    • TABLE 7: FACT SHEET OF CVD FATALITIES (MILLIONS/%)
    • TABLE 8: PRICE DIFFERENCE IN INDIA AND THE UNITED STATES FOR CARDIAC-RELATED SURGERIES ($)
    • TABLE 9: HIGHEST DEATH RATE FOR HEART DISEASE, STROKE AND HIGH BLOOD PRESSURE BY COUNTRY, 2014 (PER 100,000 MEN AND WOMEN, AGES 35 TO 74)
    • TABLE 10: ADULT MORTALITY FROM CARDIOVASCULAR DISEASE AND DIABETES BY REGION, 2008 (ADULTS AGED 30-70, RATE PER 100,000 POPULATION)
    • TABLE 11: AMERICAN HEART ASSOCIATION DISEASE STATISTICS PREVALENCE AND MORTALITY, CARDIOVASCULAR DISEASE IN THE UNITED STATES, 2009 AND 2010
    • TABLE 12: LEADING U.S. CARDIOLOGY AND HEART SURGERY INSTITUTIONS, 2014-2015
    • TABLE 13: MALE CVD DEATHS IN EUROPE BY COUNTRY, 2005-2010 (NO/%)
    • TABLE 14: LEADING GERMAN CARDIOLOGY AND HEART SURGERY INSTITUTIONS
    • TABLE 15: LEADING HOSPITALS IN THE U.K. OFFERING ADULT CARDIAC SURGERY
    • TABLE 16: LEADING JAPANESE CARDIOLOGY AND HEART SURGERY INSTITUTIONS
    • TABLE 17: LEADING INDIAN CARDIOLOGY AND HEART SURGERY INSTITUTIONS
    • TABLE 18: GLOBAL MARKET FOR TRADITIONAL CARDIOVASCULAR SURGICAL DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 19: GLOBAL MARKET FOR OPEN-HEART SURGERY AND CABG-RELATED DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: GLOBAL MARKET FOR BEATING HEART SURGERY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 21: GLOBAL MARKET FOR TRANSMYOCARDIAL REVASCULARIZATION DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: LEADING MANUFACTURERS OF CARDIOPROSTHETIC SURGERY DEVICES
    • TABLE 23: GLOBAL MARKET FOR TOTAL ARTIFICIAL HEARTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET FOR VENTRICULAR ASSIST DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: LEADING VAD SUPPLIERS, 2014 AND 2015 ($ MILLIONS)
    • TABLE 26: GLOBAL MARKET FOR HEART VALVES EXCLUDING TAVI SYSTEMS, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: LEADING HEART VALVE SUPPLIERS, 2014 ($ MILLIONS/%)
    • TABLE 28: GLOBAL MARKET FOR INTERVENTIONAL CARDIOVASCULAR SURGICAL DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: GLOBAL MARKET FOR PCI BALLOON CATHETERS AND GUIDEWIRES, THROUGH 2020 ($ MILLIONS)
    • TABLE 30: LEADING MANUFACTURERS OF CORONARY ARTERY STENTS
    • TABLE 31: GLOBAL MARKET FOR CORONARY ARTERY STENTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 32: GLOBAL MARKET FOR TRANSCATHETER AORTIC VALVE IMPLANTATION SYSTEMS, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: GLOBAL MARKET FOR RENAL DENERVATION SYSTEMS, THROUGH 2020 ($ MILLIONS)
    • TABLE 34: GLOBAL MARKET FOR ROBOTIC SURGERY SYSTEMS FOR CARDIOVASCULAR PROCEDURES, THROUGH 2020 ($ MILLIONS)
    • TABLE 35: MOST COMMON TYPES OF ARRHYTHMIAS
    • TABLE 36: GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR LEFT ATRIAL APPENDAGE EXCLUSION DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR CARDIAC PACEMAKERS AND CRT-PS, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: GLOBAL MARKET FOR DEFIBRILLATORS AND CRT-DS, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: GLOBAL MARKET FOR CARDIAC ABLATION SYSTEMS, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: MAJOR ACQUISITIONS BY CARDIOVASCULAR SURGERY DEVICE SUPPLIERS, 2008-2015
    • TABLE 42: RECENT FDA RECALLS OF CARDIOVASCULAR SURGERY DEVICES
    • TABLE 43: U.S. CARDIAC PACEMAKER AND PACEMAKER-RELATED PATENTS, JANUARY 2011-DECEMBER 2015
    • TABLE 44: U.S. CARDIAC IMPLANTABLE DEIBRILLATOR AND DEFIBRILLATOR-RELATED PATENTS, JANUARY 2011-DECEMBER 2015
    • TABLE 45: U.S. CARDIAC-RELATED AND CORONARY ARTERY STENT PATENTS, JANUARY 2011-MAY 2016
    • TABLE 46: U.S. CARDIAC CATHETER AND RELATED PATENTS, JANUARY 2011-JANUARY 2016
    • TABLE 47: U.S. CARDIAC VALVES AND RELATED-EQUIPMENT PATENTS, JANUARY 2011-MAY 2016
    • TABLE 48: ABBOTT CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 49: ABIOMED CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 50: ATRICURE CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 51: BIOSENSORS INTERNATIONAL CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 52: BIOTRONIK CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 53: BOSTON SCIENTIFIC CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 54: C. R. BARD ELECTROPHYSIOLOGY CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 55: CARDIACASSIST CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 56: CORDIS AND BIOSENSE WEBSTER CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 57: CRYOLIFE CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 58: EDWARDS LIFESCIENCES CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 59: HEARTWARE CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 60: INTUITIVE SURGICAL CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 61: JARVIK HEART CARDIOVASCULAR SURGERY PRODUCT
    • TABLE 62: MAQUET CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 63: MEDTRONIC CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 64: MERIT MEDICAL CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 65: ON-X LIFE TECHNOLOGIES CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 66: ORBUSNEICH CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 67: ST. JUDE MEDICAL CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 68: SORIN GROUP CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 69: SPECTRANETICS CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 70: SYNCARDIA CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 71: TERUMO CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 72: THORATEC CARDIOVASCULAR SURGERY PRODUCTS
    • TABLE 73: VOLCANO CARDIOVASCULAR SURGERY PRODUCTS

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014 AND 2020 (%)
    • FIGURE 1: VENTURE CAPITAL FUNDING IN HEALTHCARE IT, 2013 AND 2014 ($ BILLIONS)
    • FIGURE 2: ESSENTIAL ELEMENTS FOR CVIS
    • FIGURE 3: PREVALENCE OF ANGINA PECTORIS BY AGE & SEX (%)
    • FIGURE 4: PREVALENCE OF CAD BY AGE, 2014 (%)
    • FIGURE 5: GLOBAL MARKET FOR THERAPEUTIC APPLICATIONS FOR HYBRID OPERATING ROOMS
    • FIGURE 6: U.S. MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • FIGURE 7: EUROPE MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • FIGURE 8: GERMANY MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • FIGURE 9: U.K. MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • FIGURE 10: ASIA-PACIFIC MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • FIGURE 11: JAPAN MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • FIGURE 12: INDIA MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • FIGURE 13: CHINA MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, 2014-2020 ($ MILLIONS)
    • FIGURE 14: TRANSPLANTS BY ORGAN TYPE FROM JANUARY 1988 TO MAY 2016 (%/NO.)
    • FIGURE 15: GLOBAL MARKET SHARES OF VENTRICULAR ASSIST DEVICE SUPPLIERS, 2014 (%)
    • FIGURE 16: GLOBAL MARKET SHARES OF LEADING HEART VALVE SUPPLIERS, 2014 (%)
    • FIGURE 17: GLOBAL MARKET SHARE FOR CORONARY STENT SUPPLIERS BY COMPANY, 2014 (%)
    • FIGURE 18: GLOBAL MARKET SHARE FOR CORONARY STENT SUPPLIERS BY REGION, 2020 (%)
    • FIGURE 19: MAJOR RESTRAINTS FOR ADOPTION OF TRANSCATHETER AORTIC VALVE IMPLANTATION (%)
    • FIGURE 20: AVERAGE QUOTED PRICE: DA VINCI ROBOT MODELS, 2014 ($ MILLIONS)
    • FIGURE 21: GLOBAL MARKET SHARE FOR LEADING CARDIAC PACEMAKERS AND CRT-PS SUPPLIERS, 2014 (%)
    • FIGURE 22: GLOBAL MARKET SHARE FOR LEADING DEFIBRILLATOR AND CRT-D SUPPLIERS, 2014 (%)
Back to Top
전화 문의
F A Q